Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Grosicki S, Simonova M, Spicka I, Pour L, Kriachok I, Gavriatopoulou M, Pylypenko H, Auner HW, Leleu X, Doronin V, Usenko G, Bahlis NJ, Hajek R, Benjamin R, Dolai TK, Sinha DK, Venner CP, Garg M, Gironella M, Jurczyszyn A, Robak P, Galli M, Wallington-Beddoe C, Radinoff A, Salogub G, Stevens DA, Basu S, Liberati AM, Quach H, Goranova-Marinova VS, Bila J, Katodritou E, Oliynyk H, Korenkova S, Kumar J, Jagannath S, Moreau P, Levy M, White D, Gatt ME, Facon T, Mateos MV, Cavo M, Reece D, Anderson LD Jr, Saint-Martin JR, Jeha J, Joshi AA, Chai Y, Li L, Peddagali V, Arazy M, Shah J, Shacham S, Kauffman MG, Dimopoulos MA, Richardson PG, Delimpasi S. Grosicki S, et al. Among authors: kumar j. Lancet. 2020 Nov 14;396(10262):1563-1573. doi: 10.1016/S0140-6736(20)32292-3. Lancet. 2020. PMID: 33189178 Clinical Trial.
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study.
Kumar L, Melinkeri S, Ganesan P, Kumar J, Biswas G, Kilara N, Pathalingappa H, Prasad S, Jain M, Mishra SK, Prasad S, Boyella PK, Sahoo RK, Bondarde S, Shah S, Rege M, Deb U, Korde T, Dixit J. Kumar L, et al. Among authors: kumar j. Future Oncol. 2024 Feb;20(4):191-205. doi: 10.2217/fon-2023-0842. Epub 2023 Dec 20. Future Oncol. 2024. PMID: 38116642 Free article. Clinical Trial.
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.
Kathrotiya M, Radhakrishnan V, Bhave SJ, Nag A, Arora N, Roychoudhry M, Parihar M, Mishra D, Nair R, Chandy M, Kumar J. Kathrotiya M, et al. Among authors: kumar j. Indian J Cancer. 2023 Oct 1;60(4):486-492. doi: 10.4103/ijc.ijc_78_22. Epub 2024 Jan 23. Indian J Cancer. 2023. PMID: 38258869 Free article. Review.
Cytomegalovirus reactivation and disease amongst patients with allogeneic haematopoietic stem cell transplantation in Eastern India: Epidemiology, outcome and healthcare cost.
Kumar M, Roychowdhury M, Kumar J, Harishankar A, Sinha S, Bhave SJ, Chakrapani A, Radhakrishnan V, Nair R, Bhattacharya S, Chandy M. Kumar M, et al. Among authors: kumar j. Indian J Med Microbiol. 2018 Jan-Mar;36(1):49-53. doi: 10.4103/ijmm.IJMM_17_269. Indian J Med Microbiol. 2018. PMID: 29735826 Free article.
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review.
Radhakrishnan VS, Bajaj R, Raina V, Kumar J, Bhave SJ, Sukumaran Nair RK, Nag A, Arun I, Zameer L, Dey D, Arora N, Parihar M, Das J, Achari RB, Mishra DK, Chandy M, Nair R. Radhakrishnan VS, et al. Among authors: kumar j. Front Oncol. 2022 Jan 21;11:796270. doi: 10.3389/fonc.2021.796270. eCollection 2021. Front Oncol. 2022. PMID: 35127505 Free PMC article.
Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope.
Kathrotiya M, Radhakrishnan VS, Bhave SJ, Kumar J, Roychowdhury M, Arun I, Das J, Chandy M, Nair R. Kathrotiya M, et al. Among authors: kumar j. Clin Case Rep. 2020 Dec 20;9(2):873-877. doi: 10.1002/ccr3.3673. eCollection 2021 Feb. Clin Case Rep. 2020. PMID: 33598263 Free PMC article.
FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.
Gupta N, Parihar M, Banerjee S, Brahma S, Pawar R, Rath A, Shewale S, Singh M, Sasikumaran Nair Remani A, Krishnan S, Bhatacharyya A, Das A, Kumar J, Bhave S, Radhakrishnan V, Nair R, Chandy M, Mishra D, Arora N. Gupta N, et al. Among authors: kumar j. Cytometry B Clin Cytom. 2019 Sep;96(5):359-367. doi: 10.1002/cyto.b.21765. Epub 2019 Feb 4. Cytometry B Clin Cytom. 2019. PMID: 30715800 Free article.
A Systematic Cytogenetic Strategy to Identify Masked Hypodiploidy in Precursor B Acute Lymphoblastic Leukemia in Low Resource Settings.
Gupta T, Arun SR, Babu GA, Chakrabarty BK, Bhave SJ, Kumar J, Radhakrishnan V, Krishnan S, Ghara N, Arora N, Mishra DK, Parihar M. Gupta T, et al. Among authors: kumar j. Indian J Hematol Blood Transfus. 2021 Oct;37(4):576-585. doi: 10.1007/s12288-021-01409-w. Epub 2021 Feb 26. Indian J Hematol Blood Transfus. 2021. PMID: 34690454 Free PMC article.
Low Incidence of Central Venous Catheter-Related Bloodstream Infections in Stem Cell Transplant Patients in Eastern India Despite High Community Burden of Multidrug-Resistant Pathogens.
Roychowdhury M, Kumar J, Chakrapani A, Jayant Bhave S, Krishnan S, Thambudorai R, Bhattacharya S, Chandy M. Roychowdhury M, et al. Among authors: kumar j. Infect Control Hosp Epidemiol. 2016 May;37(5):619-20. doi: 10.1017/ice.2016.18. Epub 2016 Feb 9. Infect Control Hosp Epidemiol. 2016. PMID: 26856631 No abstract available.
2,562 results